Indazole

Indazole

SCHEMBL4310146

c1ccc2[nH]ncc2c1.c1ccc2c(c1)OCO2

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.68
IDO1 P14902 1/20 0.68
CDK2 P24941 1/20 0.68
ABCB1 P08183 1/20 0.59
ABCG2 Q9UNQ0 1/20 0.50
DYRK1A Q13627 3/20 0.42
FGFR1 P11362 1/20 0.42
DYRK3 O43781 1/20 0.42
CLK1 P49759 1/20 0.42
CLK2 P49760 1/20 0.42
CLK3 P49761 1/20 0.42
GSK3B P49841 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
DYRK2 Q92630 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
KMT2A Q03164 3/20 0.40
NOS1 P29475 5/20 0.38
TRPA1 O75762 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indazole SCHEMBL1221882 0.82 HSP90AA1 (1.00) HSP90AA1IDO1CDK2ABCB1DYRK1A
Indazole SCHEMBL29355507 0.82
Indazole SCHEMBL6295 0.82
Indazole SCHEMBL5221603 0.80 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1DYRK1A
Indazole SCHEMBL21058156 0.80 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1DYRK1A
Indazole SCHEMBL9407408 0.80 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1DYRK1A
Indazole SCHEMBL5420749 0.80 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1DYRK1A
Indazole SCHEMBL7371212 0.80 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1DYRK1A
Indazole SCHEMBL3540508 0.80 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1DYRK1A
Indazole SCHEMBL110751 0.80 HSP90AA1 (0.95) HSP90AA1IDO1CDK2ABCB1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209552-A1 Organic Compounds NOVARTIS AG 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209552-A1 Organic Compounds SLCO1B3, SLCO1B1, SLC10A6 HSP90AA1 4733/4885IDO1 2561/4885CDK2 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.